Chemical and Biological Engineering

RPI Announces $10 Million Gift from Alumnus and Entrepreneur Ajit Prabhu

Rensselaer Polytechnic Institute (RPI) has received a $10 million gift from Ajit Prabhu ’98, founder and CEO of Quest Global, to establish the Ajit Prabhu Catalyst Endowment and the Ajit Prabhu Catalyst Fund, both in support of the Office of Strategic Alliances and Translation (OSAT). Prabhu launched the fund, which will assist RPI student and faculty entrepreneurs.

Three Rensselaer Polytechnic Institute Faculty Members Honored by AAAS

Rensselaer Polytechnic Institute’s Boleslaw Szymanski, Ph.D., and Chunyu Wang, M.D. Ph.D., have been elected fellows of the American Association for the Advancement Science (AAAS). Steven Cramer, Ph.D., who was elected AAAS Fellow in 2017, was elected Council Member of the Section on Engineering.

Scientists’ Discovery Could Reduce Dependence on Animals for Vital Anti-Blood Clot Drug

Heparin, the world’s most widely used blood thinner, is used during procedures ranging from kidney dialysis to open heart surgery. Currently, heparin is derived from pig intestines, but scientists at Rensselaer Polytechnic Institute have discovered how to make it in the lab. They have also developed a path to a biomanufacturing process that could potentially revolutionize how the world gets its supply of this crucial medicine. 

RPI Doctoral Student Honored as Rising Black Scientist

Steve Eshiemogie, a doctoral student studying chemical and biological engineering at Rensselaer Polytechnic Institute, has been recognized as an honorable mention in the annual Cell Press Rising Black Scientists Awards for his essay “From village to lab: An African scientist’s quest for a sustainable future.” [MS1] More than 350 students across a range of scientific disciplines applied. 

RPI Scientists Developing Gene Editing Technology to Treat Alzheimer's

This year, Rensselaer Polytechnic Institute researchers will begin work on a radically new approach to treating and preventing genetic diseases such as Alzheimer’s.It’s thanks to a grant from the National Institutes of Health’s TARGETED Challenge, which funds scientific research on ways to deliver gene editing tools directly to cells in the human body. 

Back to top